COVID-19 has had an immediate and drastic effect on the Global Economy. Particular attention has been placed on some critical industries to include the BioPharma industry and its ability to continue full scale production with the limitations placed on the Global Supply Chain.  

On today's episode, James Zwiefel from Burns & McDonnell discusses the state of our existing global supply chain and how we move forward with the "new normal" with how companies and policy makers look to balance priorities to include the risk of a scenario like a worldwide lockdown in mind. 

What does this look like? What about maintaining a more significant reserve? How much of API production should be domestic vs international? 

This conversation is just beginning. What do you think? How has this impacted your business life?  

Want to WATCH this episode? Check it out at: https://youtu.be/XKYvQUSFWmA

Connect with James at: https://www.linkedin.com/in/jameszwiefel/

Or visit Burns and McDonnell at https://www.burnsmcd.com/